Behringer, K; Thielen, I; Mueller, H; Goergen, H; Eibl, A D; Rosenbrock, J; Halbsguth, T; Eichenauer, D A; Fuchs, M; Reiners, K S; Renno, J H; van der Ven, K; Kuehr, M; von Wolff, M; Diehl, V; Engert, A; Borchmann, P (2012). Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial. Annals of oncology, 23(7), pp. 1818-25. Oxford: Oxford University Press 10.1093/annonc/mdr575
|
Text
mdr575.pdf - Published Version Available under License Publisher holds Copyright. Download (261kB) | Preview |
In the HD14 trial, 2×BEACOPPescalated+2×ABVD (2+2) has improved the primary outcome. Compared with 4×ABVD, this benefit might be compromised by more infertility in women. Therefore, we analyzed gonadal function and fertility.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Gynaecology |
UniBE Contributor: |
von Wolff, Michael |
ISSN: |
0923-7534 |
Publisher: |
Oxford University Press |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:40 |
Last Modified: |
05 Dec 2022 14:12 |
Publisher DOI: |
10.1093/annonc/mdr575 |
Related URLs: |
|
PubMed ID: |
22228451 |
Web of Science ID: |
000306135200026 |
BORIS DOI: |
10.7892/boris.16471 |
URI: |
https://boris.unibe.ch/id/eprint/16471 (FactScience: 224121) |
Actions (login required)
 |
Edit item |